Advertisement
UK markets closed
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • FTSE 250

    20,286.03
    -45.77 (-0.23%)
     
  • AIM

    764.38
    -0.09 (-0.01%)
     
  • GBP/EUR

    1.1796
    -0.0009 (-0.07%)
     
  • GBP/USD

    1.2646
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    48,765.76
    +640.95 (+1.33%)
     
  • CMC Crypto 200

    1,277.68
    -6.15 (-0.48%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • DOW

    39,118.86
    -45.24 (-0.12%)
     
  • CRUDE OIL

    81.54
    -0.20 (-0.24%)
     
  • GOLD FUTURES

    2,339.60
    +3.00 (+0.13%)
     
  • NIKKEI 225

    39,583.08
    +241.58 (+0.61%)
     
  • HANG SENG

    17,718.61
    +2.11 (+0.01%)
     
  • DAX

    18,235.45
    +24.85 (+0.14%)
     
  • CAC 40

    7,479.40
    -51.32 (-0.68%)
     

Humana Insiders Sell US$12m Of Stock, Possibly Signalling Caution

Over the past year, many Humana Inc. (NYSE:HUM) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.

Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.

View our latest analysis for Humana

Humana Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by the insider, David Jones, for US$7.5m worth of shares, at about US$502 per share. That means that an insider was selling shares at around the current price of US$477. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.

ADVERTISEMENT

Insiders in Humana didn't buy any shares in the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
insider-trading-volume

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Does Humana Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Humana insiders own 0.2% of the company, currently worth about US$107m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Does This Data Suggest About Humana Insiders?

It doesn't really mean much that no insider has traded Humana shares in the last quarter. While we feel good about high insider ownership of Humana, we can't say the same about the selling of shares. Therefore, you should definitely take a look at this FREE report showing analyst forecasts for Humana.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.